Nausea is one of the most frequently reported side effects, affecting approximately 50% of patients taking GLP-1 medications, whilst vomiting occurs in about 15-25% of patients
Semaglutide has significant effects on several blood work markers, and anyone on an active protocol needs to understand what changes to expect and why
Quick Answer: GLP-1 medications can typically be restarted after surgery once the patient has recovered from anaesthesia, normal gastrointestinal function has returned, and they can tolerate regular oral intake without significant nausea or vomiting
Honest disclosure of past health events helps protect your safety and maximize treatment outcomes
Use the number on the back of your insurance card to speak with a representative
If weight loss is less than 5% of baseline body weight by week 16 on tirzepatide, the medication is not working adequately